| 1 |
33811277 |
10.1007/s10689-021-00244-2 |
2022 |
Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma. |
FBXO11 |
| 2 |
34472720 |
10.1002/cnr2.1545 |
2022 |
Genetic features of precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement. |
FBXO11 |
| 3 |
34625792 |
10.1182/bloodadvances.2021005682 |
2022 |
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma. |
FBXO11 |
| 4 |
31743519 |
10.1002/jcla.23122 |
2021 |
A long non-coding RNA LNBC3 facilitates non-small cell lung cancer progression by stabilizing BCL6. |
FBXO11 |
| 5 |
33914737 |
10.1371/journal.pone.0237830 |
2021 |
Loss-of-function of Fbxo10, encoding a post-translational regulator of BCL2 in lymphomas, has no discernible effect on BCL2 or B lymphocyte accumulation in mice. |
FBXO11 |
| 6 |
31042473 |
10.1016/j.celrep.2019.04.014 |
2020 |
Aryl Hydrocarbon Receptor Interacting Protein Maintains Germinal Center B Cells through Suppression of BCL6 Degradation. |
FBXO11 |
| 7 |
31365872 |
10.1016/j.celrep.2019.06.079 |
2020 |
CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 Regulation. |
FBXO11 |
| 8 |
28142295 |
10.1080/10428194.2017.1283029 |
2018 |
Identification of a tumor suppressor network in T-cell leukemia. |
FBXO11 |
| 9 |
29154209 |
10.1016/j.molimm.2017.11.011 |
2018 |
External signals regulate germinal center fate-determining transcription factors in the A20 lymphoma cell line. |
FBXO11 |
| 10 |
24349473 |
10.1371/journal.pone.0083244 |
2015 |
Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma. |
FBXO11 |
| 11 |
22113614 |
10.1038/nature10688 |
2012 |
FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas. |
FBXO11 |
Datasets
Models
